Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-14 08:20 am Unchanged | 13G | ALIGOS THERAPEUTICS INC ALGS | JANUS HENDERSON GROUP PLC JHG | 2,419,613 5.7% | 0 (Unchanged) | View |
| 2022-02-10 4:19 pm Purchase | 13G | ALIGOS THERAPEUTICS INC ALGS | Beigelman Leonid | 1,872,350 4.7% | 75,000 (+4.17%) | View |
| 2022-02-10 4:15 pm Purchase | 13G | ALIGOS THERAPEUTICS INC ALGS | BLATT LAWRENCE | 2,509,377 6.2% | 112,500 (+4.69%) | View |
| 2022-02-10 07:48 am Sale | 13G | ALIGOS THERAPEUTICS INC ALGS | WELLINGTON MANAGEMENT GROUP LLP | 1,304,321 3.06% | -2,257,650 (-63.38%) | View |
| 2022-02-04 09:12 am Sale | 13G | ALIGOS THERAPEUTICS INC ALGS | WELLINGTON MANAGEMENT GROUP LLP | 3,561,971 8.36% | -365,627 (-9.31%) | View |
| 2022-02-04 08:53 am Purchase | 13G | ALIGOS THERAPEUTICS INC ALGS | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 1,206,191 2.83% | 1,206,191 (New Position) | View |
| 2022-01-31 4:28 pm Sale | 13D | ALIGOS THERAPEUTICS INC ALGS | Novo Holdings A/S | 1,950,000 4.9% | -664,563 (-25.42%) | View |
| 2021-08-13 12:27 pm Purchase | 13G | ALIGOS THERAPEUTICS INC ALGS | Logos Global Management LP | 2,872,785 6.7% | 2,872,785 (New Position) | View |
| 2021-06-21 4:44 pm Sale | 13D | ALIGOS THERAPEUTICS INC ALGS | Versant Venture Capital VI L.P. | 1,457,937 3.8% | -485,979 (-25.00%) | View |
| 2021-06-21 4:30 pm Unchanged | 13D | ALIGOS THERAPEUTICS INC ALGS | Novo Holdings A/S | 2,614,563 7.5% | 0 (Unchanged) | View |
| 2021-05-03 4:57 pm Sale | 13D | ALIGOS THERAPEUTICS INC ALGS | Versant Venture Capital VI L.P. | 1,943,916 5.1% | -485,979 (-20.00%) | View |
| 2021-02-16 4:27 pm Purchase | 13G | ALIGOS THERAPEUTICS INC ALGS | HHLR ADVISORS LTD. | 2,165,064 5.7% | 2,165,064 (New Position) | View |
| 2021-02-16 07:03 am Purchase | 13G | ALIGOS THERAPEUTICS INC ALGS | ROCHE FINANCE LTD | 3,092,340 8.1% | 3,092,340 (New Position) | View |
| 2021-02-11 4:18 pm Purchase | 13G | ALIGOS THERAPEUTICS INC ALGS | BLATT LAWRENCE | 2,396,877 6.7% | 2,396,877 (New Position) | View |
| 2021-02-11 4:16 pm Purchase | 13G | ALIGOS THERAPEUTICS INC ALGS | Beigelman Leonid | 1,797,350 5.1% | 1,797,350 (New Position) | View |
| 2021-01-11 09:10 am Purchase | 13G | ALIGOS THERAPEUTICS INC ALGS | WELLINGTON MANAGEMENT GROUP LLP | 3,927,598 10.3% | 3,927,598 (New Position) | View |
| 2020-10-30 4:25 pm Purchase | 13D | ALIGOS THERAPEUTICS INC ALGS | Versant Venture Capital VI L.P. | 2,429,895 7.2% | 2,429,895 (New Position) | View |
| 2020-10-28 4:30 pm Purchase | 13G | ALIGOS THERAPEUTICS INC ALGS | Vivo Capital VIII LLC | 3,547,030 10.5% | 3,547,030 (New Position) | View |
| 2020-10-22 4:31 pm Purchase | 13D | ALIGOS THERAPEUTICS INC ALGS | Novo Holdings A/S | 2,614,563 7.7% | 2,614,563 (New Position) | View |
| 2020-10-22 10:01 am Purchase | 13G | ALIGOS THERAPEUTICS INC ALGS | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 1,906,191 5.34% | 1,906,191 (New Position) | View |